NEPHCURE KIDNEY INTERNATIONAL – Trademark Portfolio
Entity Type: 03
NEPHCURE KIDNEY INTERNATIONAL holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include INTERNATIONAL SOCIETY OF GLOMERULAR DISEASE. The owner is based in King of Prussia, PA.
150 S. Warner Road, Suite 402
King of Prussia, PA 19406
Showing of trademarks Trademarks
Trademark Classifications
NEPHCURE KIDNEY INTERNATIONAL's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does NEPHCURE KIDNEY INTERNATIONAL have?
NEPHCURE KIDNEY INTERNATIONAL has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does NEPHCURE KIDNEY INTERNATIONAL file in?
NEPHCURE KIDNEY INTERNATIONAL files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are NEPHCURE KIDNEY INTERNATIONAL's most well-known trademarks?
NEPHCURE KIDNEY INTERNATIONAL's registered trademark portfolio includes well-known marks such as INTERNATIONAL SOCIETY OF GLOMERULAR DISEASE. These are among 1 currently registered trademark in the portfolio.
What is NEPHCURE KIDNEY INTERNATIONAL's trademark registration success rate?
NEPHCURE KIDNEY INTERNATIONAL has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.